Esther Moga

NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma

Esther Moga, Eva Álvarez, Elisabet Cantó et al. · Experimental Hematology · 2007 · 69 citations · Full text

B-cell Lymphoma, Cpg Odn, Lymphoid Neoplasia +10

Interleukin-15 enhances rituximab-dependent cytotoxicity against chronic lymphocytic leukemia cells and overcomes transforming growth factor beta-mediated immunosuppression

Esther Moga, Elisabet Cantó, Sílvia Vidal et al. · Experimental Hematology · 2011 · 36 citations · Full text

Cytokine, Lymphoid Neoplasia, Autoimmune Disease +8

Clinical and laboratory features of anti-MAG neuropathy without monoclonal gammopathy

Elba Pascual‐Goñi, L. Aguilar, Cinta Lleixà et al. · Scientific Reports · 2019 · 34 citations · Full text

Growth Differentiation Factor 15 (GDF-15): A Novel Biomarker Associated with Poorer Respiratory Function in COVID-19

Letícia Alserawan, Patricia Peñacoba, Sandra Elizabet Orozco Echevarría et al. · Diagnostics · 2021 · 24 citations · Full text

Inflammation, Poorer Respiratory Function, Lung Inflammation +12

Bcl‐10 protein highly correlates with the expression of phosphorylated p65 NF‐κB in peripheral T‐cell lymphomas and is associated with clinical outcome

Javier Briones, Esther Moga, Íñigo Espinosa et al. · Histopathology · 2009 · 23 citations